Evidence map›Paper›PMID 22132705›Full record

ArticleThe European journal of neuroscience2011

The genetic signature of perineuronal oligodendrocytes reveals their unique phenotype.

Sara Szuchet, Joseph A Nielsen, Gabor Lovas, Miriam S Domowicz, Javier M de Velasco, Dragan Maric, Lynn D Hudson

Abstract read
In one paragraph

Article in The European journal of neuroscience, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 51 citations in OpenAlex.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Morphology of Oligodendroglial Cells.Advances in neurobiology · 2025
    Review
  9. Review
  10. Article
  11. Review
  12. Review
  13. Article
  14. AFrontiers in neuroscience · 2021
    Review
  15. Review
  16. Article
  17. Extensive Transduction and Enhanced Spread of a Modified AAV2 Capsid in the Non-human Primate CNS.Molecular therapy : the journal of the American Society of Gene Therapy · 2018
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Sara SzuchetDepartment of Neurology, 5841 S Maryland Ave., The University of Chicago, Chicago, IL 60637, USA. szuchet@neurology.bsd.uchicago.edu
Joseph A Nielsen
Gabor Lovas
Miriam S Domowicz
Javier M de Velasco
Dragan Maric
Lynn D Hudson
National Institute of Neurological Disorders and Stroke · USUniversity of Chicago · USSemmelweis University · HU

Funding

TRANSLATIONAL RESEARCH UNIVERSITY OF CHICAGO: CLINICAL TRIALSUL1RR024999 · NCRR · UNIVERSITY OF CHICAGO · PI SOLWAY, JULIAN · 2007 to 2011
$25.3M
REGULATION OF MYELIN SYNTHESISZ01NS002528 · NINDS · NEUROLOGICAL DISORDERS AND STROKE · PI HUDSON, LYNN D · 1985 to 2008
$2.7M
Intramural NIH HHS Z01 NS002528NCRR NIH HHS UL1 RR024999
6 · The paper itself

Abstract

Oligodendrocytes--best known for assembling central nervous system myelin--can be categorized as precursors, myelin-forming cells and non-myelinating perineuronal cells. Perineuronal oligodendrocytes have been well characterized morphologically and ultrastructurally, but knowledge about their function remains scanty. It has been proposed that perineuronal oligodendrocytes support neurons and, following injury, transform into myelin-synthesizing cells. Recent findings implicating perineuronal oligodendrocytes in cytoarchitectural abnormalities in the prefrontal cortex of schizophrenia and other psychiatric disorders shed new light on these cells. We have obtained the genetic signature of perineuronal oligodendrocytes by identifying gene expression differences between oligodendrocyte subpopulations using cell-specific tags, microarray technology, quantitative time-resolved polymerase chain reaction and bioinformatics tools. We show that perineuronal cells are the progeny of oligodendrocyte progenitors and, hence, are members of the oligodendrocyte lineage. Physiologically they exhibit a novel phenotype. Their expression of PDGFR-αβ and its growth factor ligand PDGF-CC sets them apart from members of their lineage as this receptor precludes their response to the same growth factors that act on myelinating cells. Their coordinate expression and context-specific usage of transcription factors Olig2, Ascl1 and Pax6, together with the prominent presence of transcription factors Pea3, Lhx2 and Otx2--not hitherto linked to the oligodendrocyte lineage--suggested a cell with features that blur the boundary between a neuron and a glial cell. But they also maintain a reservoir of untranslated transcripts encoding major myelin proteins presumably for a demyelinating episode. This first molecular characterization of perineuronal oligodendrocytes revealed the striking difference between the myelinating and non-myelinating phenotypes.

Indexed as

Cell LineageGene ExpressionPhenotypeAnimalsBiomarkersCells, CulturedGene Expression ProfilingMiceMice, Inbred C57BLMice, TransgenicMicroarray AnalysisMyelin ProteinsMyelin SheathNeuronsOligodendrogliaRatsBiomarkersMyelin ProteinsTranscription Factors

Identifiers

PMID22132705
PMCPMC4286392
OpenAlexW1602694202

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.